Kymos and Prolytic merge to become Kymos Group, a top pan-European CRO dedicated to innovative pharmaceuticals

by Kymos

With the German CRO joining the European group, Kymos will strengthen its activity in the biologics and advanced therapies market and broaden its services portfolio while offering three local sites in...

Read more

The most comprehensive map of cancer genomes to date reveals mutations decades before a tumour appears

by Centre for Genomic Regulation

An international team of scientists had today published 23 studies in the Nature journals, describing the most comprehensive map of cancer genomes from 38 types of tumours to date. The results are an ...

Read more
Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Palobiofarma announces the completion th...

by Palobiofarma

Palobiofarma S.L. is pleased to announce the “last patient last visi...

Photos Stream